Stacey Peterson-Carmichael
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Function Tests | 2 | 2016 | 105 | 0.860 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2016 | 25 | 0.510 |
Why?
|
| Respiratory Mechanics | 1 | 2016 | 6 | 0.480 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2016 | 35 | 0.470 |
Why?
|
| Critical Care | 1 | 2016 | 113 | 0.440 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 62 | 0.430 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 105 | 0.350 |
Why?
|
| Pediatrics | 1 | 2013 | 167 | 0.350 |
Why?
|
| Infant | 7 | 2020 | 1123 | 0.310 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 25 | 0.290 |
Why?
|
| Neutrophils | 1 | 2009 | 123 | 0.280 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2014 | 31 | 0.280 |
Why?
|
| Inflammation | 1 | 2009 | 557 | 0.230 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 61 | 0.170 |
Why?
|
| Laryngomalacia | 1 | 2020 | 1 | 0.160 |
Why?
|
| Airway Obstruction | 1 | 2020 | 33 | 0.160 |
Why?
|
| Endoscopy | 1 | 2020 | 56 | 0.150 |
Why?
|
| Patient Care Team | 2 | 2018 | 130 | 0.150 |
Why?
|
| Nasopharynx | 1 | 2018 | 10 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 39 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 54 | 0.130 |
Why?
|
| Program Development | 1 | 2018 | 98 | 0.130 |
Why?
|
| Humans | 11 | 2020 | 34562 | 0.130 |
Why?
|
| Lung Volume Measurements | 1 | 2016 | 4 | 0.120 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2016 | 2 | 0.120 |
Why?
|
| Ventilator Weaning | 1 | 2016 | 4 | 0.120 |
Why?
|
| Capnography | 1 | 2016 | 9 | 0.120 |
Why?
|
| Electric Impedance | 1 | 2016 | 13 | 0.120 |
Why?
|
| Pulmonary Medicine | 1 | 2016 | 15 | 0.120 |
Why?
|
| Europe | 1 | 2016 | 86 | 0.120 |
Why?
|
| Child | 4 | 2018 | 2614 | 0.110 |
Why?
|
| Societies, Medical | 1 | 2016 | 168 | 0.110 |
Why?
|
| Tracheitis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Critical Illness | 2 | 2012 | 89 | 0.110 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 4 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 15 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 27 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 191 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2012 | 37 | 0.090 |
Why?
|
| Tracheostomy | 1 | 2012 | 29 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2011 | 14 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 84 | 0.090 |
Why?
|
| Palliative Care | 1 | 2012 | 52 | 0.090 |
Why?
|
| Physical Therapy Modalities | 1 | 2011 | 84 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2012 | 214 | 0.080 |
Why?
|
| United States | 2 | 2018 | 4278 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2018 | 1355 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 51 | 0.080 |
Why?
|
| Mutation | 1 | 2013 | 532 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 439 | 0.080 |
Why?
|
| Comorbidity | 1 | 2012 | 596 | 0.080 |
Why?
|
| Functional Residual Capacity | 1 | 2009 | 1 | 0.080 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2009 | 2 | 0.080 |
Why?
|
| Metalloproteases | 1 | 2009 | 4 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 19 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2011 | 133 | 0.080 |
Why?
|
| Plethysmography | 1 | 2009 | 18 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2009 | 27 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 27 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2009 | 50 | 0.070 |
Why?
|
| Female | 7 | 2020 | 21532 | 0.070 |
Why?
|
| Male | 5 | 2020 | 20740 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2009 | 1910 | 0.050 |
Why?
|
| Adolescent | 3 | 2018 | 3805 | 0.040 |
Why?
|
| Sleep, REM | 1 | 2020 | 6 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cyanosis | 1 | 2020 | 3 | 0.040 |
Why?
|
| Oximetry | 1 | 2020 | 33 | 0.040 |
Why?
|
| Polysomnography | 1 | 2020 | 41 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 20 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 30 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2018 | 44 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3825 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2018 | 71 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2018 | 56 | 0.030 |
Why?
|
| Bacteria | 1 | 2018 | 56 | 0.030 |
Why?
|
| Health Services Research | 1 | 2018 | 82 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 922 | 0.030 |
Why?
|
| Mediastinal Emphysema | 1 | 2014 | 2 | 0.030 |
Why?
|
| Pneumothorax | 1 | 2014 | 8 | 0.030 |
Why?
|
| Young Adult | 2 | 2011 | 2831 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 6 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2013 | 21 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 37 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 62 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 40 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 319 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 193 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 389 | 0.020 |
Why?
|
| Early Ambulation | 1 | 2011 | 8 | 0.020 |
Why?
|
| Zanamivir | 1 | 2011 | 1 | 0.020 |
Why?
|
| Oseltamivir | 1 | 2011 | 6 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2011 | 129 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 730 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 110 | 0.020 |
Why?
|
| Adult | 1 | 2011 | 10030 | 0.010 |
Why?
|